Clinical trial
A Phase II Trial of Prostate Stereotactic Radiotherapy
NCT02313298 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Prostate Stereotactic Radiotherapy
- Lead sponsor
- National Cancer Centre, Singapore
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2013
- Completion date
- December 31, 2021
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer